Back to Search
Start Over
Optimising fluorescein diacetate sputum smear microscopy for assessing patients with pulmonary tuberculosis
- Source :
- PLoS ONE, PLoS ONE, Vol 14, Iss 4, p e0214131 (2019)
- Publication Year :
- 2019
- Publisher :
- Public Library of Science, 2019.
-
Abstract
- BackgroundAssessing Mycobacterium tuberculosis (TB) viability by fluorescein diacetate (FDA) microscopy can predict TB culture results, treatment response and infectiousness. However, diverse methods have been published. We aimed to optimise FDA microscopy, minimising sputum processing, biohazard and complexity for use in resource-constrained settings.Methods and resultsOptimization: Patients with smear-positive pulmonary TB before treatment and healthy control participants provided sputa. These were divided into equal aliquots that were tested directly or after NaOH centrifuge-decontamination. Each aliquot was cultured and used to prepare slides (n = 80). FDA microscopy used: 1 or 3 drops of sputum; with/out acid-alcohol wash; with/out phenol sterilization; with 0/30/60 seconds KMnO4 quenching. Control samples all had negative culture and microscopy results. FDA microscopy had higher sensitivity when performed directly (without centrifuge-decontamination) on 1 drop of sputum (P0.1). Validation: The 2 protocols that performed best in the optimization experiments were reassessed operationally by comparing duplicate slides (n = 412) stained with KMnO4 quenching for 30 versus 60 seconds. FDA microscopy results were similar (P = 0.4) and highly reproducible, with 97% of counts agreeing within +/-1 logarithm. Storage: Smear microscopy slides and aliquots of the sputum from which they were made were stored for 4 weeks. Twice-weekly, paired slides (n = 80) were stained with freshly prepared versus stored FDA and read quantitatively. Storing sputum, microscopy slides or FDA solution at 4°C or room temperature had no effect on FDA microscopy results (all P>0.2). Cost: Material costs for each slide tested by FDA microscopy using reagents purchased locally were USD $0.05 and required the same equipment, time and skills as auramine acid-fast microscopy.ConclusionsWe recommend a simple, bio-secure protocol for FDA microscopy that provides sensitive and repeatable results without requiring centrifugation.
- Subjects :
- Fluorescein diacetate
Bacterial Diseases
respiratory tract disease assessment
Physiology
Smear microscopy
chemistry.chemical_compound
0302 clinical medicine
Fluorescence Microscopy
sensitivity analysis
Microscopy
Medicine and Health Sciences
030212 general & internal medicine
Fluorescein
Staining
Multidisciplinary
Organic Compounds
Light Microscopy
lung tuberculosis
sputum smear
3. Good health
Body Fluids
Multidisciplinary Sciences
Actinobacteria
Separation Processes
Chemistry
Infectious Diseases
Physical Sciences
microscopy
Medicine
Science & Technology - Other Topics
Female
medicine.symptom
Anatomy
Research Article
Adult
Tuberculosis
General Science & Technology
Science
030231 tropical medicine
DIAGNOSIS
Research and Analysis Methods
Article
03 medical and health sciences
Acetones
Phenols
false positive result
Pulmonary tuberculosis
process optimization
medicine
Humans
false negative result
controlled study
human
INFECTIOUSNESS
purl.org/pe-repo/ocde/ford#1.06.01 [https]
Tuberculosis, Pulmonary
reproducibility
Distillation
centrifugation
Chromatography
Science & Technology
Bacteria
business.industry
Diagnostic Tests, Routine
Organic Chemistry
Sputum
Organisms
Chemical Compounds
Biology and Life Sciences
Mycobacterium tuberculosis
medicine.disease
Tropical Diseases
Mucus
chemistry
Specimen Preparation and Treatment
fluorescein diacetate
storage temperature
purl.org/pe-repo/ocde/ford#3.02.07 [https]
business
clinical protocol
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- PLoS ONE, PLoS ONE, Vol 14, Iss 4, p e0214131 (2019)
- Accession number :
- edsair.doi.dedup.....7a1135f5f22baa97e86d6a2cedf79952